Long before pharmaceutical and medical device sales reps make their pitches to physicians, ophthalmic drug and device developers run their products through years of clinical trials. Most of the time, they turn to third-party vendors to get them across the finish line. One of the most important partners in that process are clinical research organizations (CROs), which manage all aspects of clinical trials from discovery through to regulatory approval and commercialization.

With offices in southern California and India, CBCC Global, a CRO with ophthalmology expertise, provides a range of services to help drug and device companies take their products to the next level. Under the leadership of CEO Manoj Vyas, CBCC has expanded its U.S. and India markets and plans to strengthen its presence in Europe. Already well-versed in Phase I – IV clinical trials, CBCC plans to further diversify to offer preclinical support.

CBCC also champions innovation through strategic relationships: it recently entered into a joint agreement with StepWise Medical, a health technology start-up accelerator that focuses on ophthalmology and optometry.

With host Ehsan Sadri, MD, Manoj and Sanjeev Ganatra, CBCC’s Senior VP of Sales and Marketing, discuss what’s next for CBCC and why they appreciate the close-knit ophthalmology community. They also discuss what they gained from having a few good mentors to guide them — not unlike how they now guide operations for their clients’ innovations today.

Listen to the podcast today to discover:

• What brought both Manoj and Sanjeev to CBCC and how mentorship helped move their careers forward.
• The road ahead for CBCC and its “sweet spot:” ophthalmology drugs and medical devices.
• The advantage of having U.S. offices near Orange County, CA, which boasts an impressive ophthalmology ecosystem.
• Steps to take early and often to stand apart in a competitive industry.

[Listen Now]